About

Dominik Höchli has served as an independent director of Abivax since April 2025. He has over two decades of leadership experience in global biopharma, most notably a 20-year tenure at AbbVie/Abbott, where he was Vice President of Global Marketing for Immunology and later Head of Global Medical Affairs. He served as Interim Chief Executive Officer of Catapult Therapeutics from 2021 to 2024, founded the pharmaceutical strategy consultancy Abinode, and serves on the board of Molecular Partners AG, where he sits on the Audit Committee and the Research & Development Committee. He received his medical degree (M.D.) from the University of Bern, Switzerland. He is a member of the Science and Clinical Committee and the Commercial Committee.

Roles

Abivax S.A.
Independent Director · Current role
April 2025–present
AbbVie / Abbott
VP Global Marketing, Immunology; Head of Global Medical Affairs
~20 years
Catapult Therapeutics
Interim Chief Executive Officer · Hematology-oncology
2021 - 2024
Abinode
Founder · Pharmaceutical strategy consulting
present

External Roles

Molecular Partners AG
Director (Audit and R&D Committees)
present

Director Compensation

FY 2025
Gross fees earned
€86,250
ComponentDirector attendance fees / remuneration earned in FY2025 (paid in euros); appointed to the Board in 2025 (partial-year)
Total
€86,250

Also at Abivax S.A.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.